Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Weber

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|July 21, 1995
Clinical trials with IL-6J S Weber
Current Topics in Microbiology and Immunology|January 1, 1988
MHC class I gene expression by tumors: immunotherapeutic implicationsJ S Weber, G Jay
Current Opinion in Oncology|February 27, 2001
Novel immunologic approaches to the management of malignant melanomaJ S Weber, A Aparicio
Journal of the National Cancer Institute|May 2, 1990
Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytesJ S Weber, S A Rosenberg
The Journal of Clinical Investigation|March 10, 2001
How much help does a vaccine-induced T-cell response need?J S Weber, J J Mulé
Cancer Research|October 15, 1988
Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitroJ S Weber, S A Rosenberg
Archives of Environmental Health|July 1, 1979
Carbon monoxide: a hazard to fire fightersR J Barnard, J S Weber
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humansG Mastorakos, G P Chrousos, J S Weber
Genesis (New York, N.Y. : 2000)|April 5, 2000
Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strainsJ S Weber, A Salinger, M J Justice
Journal of the National Cancer Institute|June 21, 1995
Hypersensitivity reactions to chemotherapy agents in patients receiving chemoimmunotherapy with high-dose interleukin 2G R Heywood, S A Rosenberg, J S Weber
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|July 21, 1995
Clinical trials with IL-6J S Weber
Current Topics in Microbiology and Immunology|January 1, 1988
MHC class I gene expression by tumors: immunotherapeutic implicationsJ S Weber, G Jay
Current Opinion in Oncology|February 27, 2001
Novel immunologic approaches to the management of malignant melanomaJ S Weber, A Aparicio
Journal of the National Cancer Institute|May 2, 1990
Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytesJ S Weber, S A Rosenberg
The Journal of Clinical Investigation|March 10, 2001
How much help does a vaccine-induced T-cell response need?J S Weber, J J Mulé
Cancer Research|October 15, 1988
Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitroJ S Weber, S A Rosenberg
Archives of Environmental Health|July 1, 1979
Carbon monoxide: a hazard to fire fightersR J Barnard, J S Weber
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humansG Mastorakos, G P Chrousos, J S Weber
Genesis (New York, N.Y. : 2000)|April 5, 2000
Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strainsJ S Weber, A Salinger, M J Justice
Journal of the National Cancer Institute|June 21, 1995
Hypersensitivity reactions to chemotherapy agents in patients receiving chemoimmunotherapy with high-dose interleukin 2G R Heywood, S A Rosenberg, J S Weber
Pageof 6